T cell receptor alpha variable 9-2 (TRAV9-2)

The T cell receptor alpha variable 9-2 (TRAV9-2) is a gene segment encoding a variable (V) region of the alpha chain in the T cell receptor (TCR) complex[1][3]. The TCR is a heterodimeric protein expressed on the surface of T lymphocytes and is essential for the adaptive immune response by enabling the recognition of foreign antigens. Each alpha chain is formed by somatic recombination of multiple V and J gene segments during T cell development, contributing to the immense diversity of TCRs. The TRAV9-2 segment encodes a specific part of the antigen-binding site. Its product participates in recognition of antigens presented by the major histocompatibility complex (MHC) on antigen-presenting cells. While T cell therapies, autoimmune diseases, and certain lymphoid cancers often involve or analyze TCRs, there are currently no therapeutics or diagnostics specifically targeting TRAV9-2. The TCR complex, including the variable domains, is crucial for T cell signaling, immune activation, and maintaining self-tolerance[1][3][5].

Other names

TCRAV22S1TCRAV9S2TRAV92TRAV9-2

No known mechanism of action for drugs targeting this specific variable region